Patents by Inventor Guoxiang Wang

Guoxiang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11943221
    Abstract: Aspects of the invention include systems and methods configured to prevent masquerading service attacks. A non-limiting example computer-implemented method includes sending, from a first server in a cloud environment, a communication request comprising an application programming interface (API) key and a first server identifier to an identity and access management (IAM) server of the cloud environment. The API key can be uniquely assigned by the IAM server to a first component of the first server. The first server receives a credential that includes a token for the first component and sends the credential to a second server. The second server sends the credential, a second server identifier, and an identifier for a second component of the second server to the IAM server. The second server receives an acknowledgment from the IAM server and sends the acknowledgment to the first server.
    Type: Grant
    Filed: August 25, 2021
    Date of Patent: March 26, 2024
    Assignee: International Business Machines Corporation
    Inventors: Sen Wang, Mei Liu, Si Bo Niu, Wen Yi Gao, Zong Xiong Z X Wang, Guoxiang Zhang, Xiao Yi Tian, Xian Wei Zhang
  • Patent number: 11638953
    Abstract: The present disclosure provides a method for collecting parameters for casting solidification simulation and a gridded design method for a pouring and riser system, comprising calculating thermodynamic parameters of a superalloy; obtaining cooling curves of the superalloy with different thickness; measuring a linear expansion coefficient of the superalloy as a function of temperature; the design method comprising: simulating a solidification process with tubular features of different thickness, and determining a feeding distance of the features of different thickness; establishing a gridded pouring and riser system, dividing the casting into a plurality of modules according to the thickness, and dividing a cell inside each module, and ensuring that a size of the cell is less than the feeding distance with the thickness; simulating filling and solidification of castings and the gridded pouring and riser system, and analyzing simulation results of defects.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: May 2, 2023
    Inventors: Maodong Kang, Jun Wang, Jianzhong Li, Guoxiang Wang, Haiyan Gao, Baode Sun
  • Patent number: 11358955
    Abstract: Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): wherein Ar, R1-R6 are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: June 14, 2022
    Assignee: IMPACT THERAPEUTICS, INC.
    Inventors: Sui Xiong Cai, Ye Edward Tian, Haijun Dong, Qingbing Xu, Lizhen Wu, Lijun Liu, Yangzhen Jiang, Qingli Bao, Guoxiang Wang, Feng Yin, Chengyun Gu, Xiuhua Hu, Xiaozhu Wang, Sishun Kang, Shengzhi Chen
  • Publication number: 20220143687
    Abstract: The present disclosure provides a method for collecting parameters for casting solidification simulation and a gridded design method for a pouring and riser system, comprising calculating thermodynamic parameters of a superalloy; obtaining cooling curves of the superalloy with different thickness; measuring a linear expansion coefficient of the superalloy as a function of temperature; the design method comprising: simulating a solidification process with tubular features of different thickness, and determining a feeding distance of the features of different thickness; establishing a gridded pouring and riser system, dividing the casting into a plurality of modules according to the thickness, and dividing a cell inside each module, and ensuring that a size of the cell is less than the feeding distance with the thickness; simulating filling and solidification of castings and the gridded pouring and riser system, and analyzing simulation results of defects.
    Type: Application
    Filed: January 27, 2022
    Publication date: May 12, 2022
    Inventors: Maodong KANG, Jun WANG, Jianzhong LI, Guoxiang WANG, Haiyan GAO, Baode SUN
  • Publication number: 20210128385
    Abstract: A support pad coupling mechanism for a surgical table extension unit and a surgical table are disclosed. The surgical table extension unit includes an extension adapter and a support pad. A lower side of the support pad is provided with two coupling plates that are perpendicular to the support pad. Each coupling plate is provided with a hook portion and a first position-limiting post. The first position-limiting posts extend along a direction perpendicular to the coupling plates. The extension adapter is provided with two second position-limiting posts that cooperate with the hook portions and two position-limiting recessed portions that cooperate with the first position-limiting posts. When the support pad and the extension adapter are coupled together, the first position-limiting posts are positioned in the position-limiting recessed portions and the hook portions are hooked onto the second position-limiting posts.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 6, 2021
    Inventors: Debao Martin MA, Jipeng WANG, Qiang HAO, Aaron FOO, Guoxiang WANG
  • Publication number: 20190270732
    Abstract: Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): wherein Ar, R1-R6 are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
    Type: Application
    Filed: May 17, 2019
    Publication date: September 5, 2019
    Applicant: IMPACT Therapeutics, Inc.
    Inventors: Sui Xiong CAI, Ye Edward TIAN, Haijun DONG, Qingbing XU, Lizhen WU, Lijun LIU, Yangzhen JIANG, Qingli BAO, Guoxiang WANG, Feng YIN, Chengyun GU, Xiuhua HU, Xiaozhu WANG, Sishun KANG, Shengzhi CHEN
  • Patent number: 10316027
    Abstract: Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): wherein Ar, R1-R6, are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: June 11, 2019
    Assignee: Impact Therapeutics, Inc.
    Inventors: Sui Xiong Cai, Ye Edward Tian, Haijun Dong, Qingbing Xu, Lizhen Wu, Lijun Liu, Yangzhen Jiang, Qingli Bao, Guoxiang Wang, Feng Yin, Chengyun Gu, Xiuhua Hu, Xiaozhu Wang, Sishun Kang, Shengzhi Chen
  • Publication number: 20180215741
    Abstract: Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): wherein Ar, R1-R6, are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
    Type: Application
    Filed: March 26, 2018
    Publication date: August 2, 2018
    Inventors: Sui Xiong CAI, Ye Edward TIAN, Haijun DONG, Qingbing XU, Lizhen WU, Lijun LIU, Yangzhen JIANG, Qingli BAO, Guoxiang WANG, Feng YIN, Chengyun GU, Xiuhua HU, Xiaozhu WANG, Sishun KANG, Shengzhi CHEN
  • Patent number: 9926304
    Abstract: Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): wherein Ar, R1-R6 are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: March 27, 2018
    Assignee: Impact Therapeutics, Inc.
    Inventors: Sui Xiong Cai, Ye Edward Tian, Haijun Dong, Qingbing Xu, Lizhen Wu, Lijun Liu, Yangzhen Jiang, Qingli Bao, Guoxiang Wang, Feng Yin, Chengyun Gu, Xiuhua Hu, Xiaozhu Wang, Sishun Kang, Shengzhi Chen
  • Publication number: 20160237070
    Abstract: Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): wherein Ar, R1-R6 are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
    Type: Application
    Filed: February 12, 2016
    Publication date: August 18, 2016
    Inventors: Sui Xiong CAI, Ye TIAN, Haijun DONG, Qingbing XU, Lizhen WU, Lijun LIU, Yangzhen JIANG, Qingli BAO, Guoxiang WANG, Feng YIN, Chengyun GU, Xiuhua HU, Xiaozhu WANG, Sishun KANG, Shengzhi CHEN
  • Patent number: 9102631
    Abstract: Disclosed are novel 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs thereof, represented by the Formula 1: wherein Ar, A, R1, R3-R6 are defined herein. Compounds having Formula I are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity, such as cancer.
    Type: Grant
    Filed: November 1, 2012
    Date of Patent: August 11, 2015
    Assignee: IMPACT Therapeutics, Inc.
    Inventors: Suixiong Cai, Ye Edward Tian, Lizhen Wu, Lijun Liu, Xiaozhu Wang, Yangzhen Jiang, Guoxiang Wang, Xiuyan Zhang, Qingbing Xu, Zheng Meng
  • Publication number: 20150207001
    Abstract: The subject invention is related to a colored glass and a solar cell assembly comprising the same. The subject invention provides a colored glass comprising a glass substrate; and a colored coating formed on the glass substrate, wherein the colored coating comprises an inorganic film-forming material, a pigment and an adhesive. The subject invention also provides a solar cell assembly comprising: a front glass substrate; the aforementioned colored glass; and a photovoltaic cell sealed between the front glass substrate and the colored glass. The colored glass of the subject invention has a good thermal conductivity, improved waterproof performance, mechanical properties and weather resistance such that the colored glass is not only aesthetically pleasing but also useful as a backside protection material of a solar cell assembly for long-term outdoor use.
    Type: Application
    Filed: November 21, 2014
    Publication date: July 23, 2015
    Inventors: Jinxi Lin, Jinhan Lin, Ling Chen, Guoxiang Wang, Zhilong Ni
  • Publication number: 20150144188
    Abstract: The subject invention is related to a black glass and a solar cell assembly comprising the same. The subject invention provides a black glass comprising a glass substrate; and a black coating formed on the glass substrate, wherein the black coating comprises an inorganic film-forming material, a black pigment and an adhesive. The subject invention also provides a solar cell assembly comprising: a front glass substrate; the aforementioned black glass; and a photovoltaic cell sealed between the front glass substrate and the black glass. The black glass of the subject invention has a good thermal conductivity, waterproof performance, mechanical properties and weather resistance such that the black glass is not only aesthetically pleasing but also useful as a backside protection material of a solar cell assembly for long-term outdoor use.
    Type: Application
    Filed: November 21, 2014
    Publication date: May 28, 2015
    Applicant: CHANGZHOU ALMADEN CO., LTD.
    Inventors: Jinxi Lin, Jinhan Lin, Ling Chen, Guoxiang Wang, Zhilong Ni
  • Publication number: 20140290714
    Abstract: The present invention discloses a glass coated with a highly reflective film and the process for preparing the same. The present invention provides a glass coated with a highly reflective film comprising a glass substrate and a highly reflective film formed thereon, wherein the highly reflective film comprises inorganic film-forming materials, adhesives and solvents. The present invention also provides a process for preparing a glass coated with a highly reflective film comprising the following steps: (1) preparing a coating solution; (2) coating the coating solution on a glass; and (3) curing the coated glass. The coated glass is white. Compared with conventional fluorine-containing back sheet materials, the coated glass of the present invention has excellent reflectivity, thermal conductivity, water resistance, mechanical properties and weatherability. Further, the manufacture of the present invention is simple, cost efficient and suitable for large-scale commercialization.
    Type: Application
    Filed: March 26, 2014
    Publication date: October 2, 2014
    Applicant: Changzhou Almaden Co., Ltd.
    Inventors: JINXI LIN, Jinhan Lin, Ling Chen, Guoxiang Wang, Zhilong Ni
  • Publication number: 20140275711
    Abstract: Disclosed are novel 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs thereof, represented by the Formula I, wherein Ar, A, B, R3-R6 are defined herein. Compounds having Formula I are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity, such as cancer.
    Type: Application
    Filed: November 1, 2012
    Publication date: September 18, 2014
    Inventors: Suixiong Cai, Ye Edward Tian, Lizhen Wu, Lijun Liu, Xiaozhu Wang, Yangzhen Jiang, Guoxiang Wang, Xiuyan Zhang, Qingbing Xu, Zheng Meng
  • Publication number: 20140023642
    Abstract: Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones thereof, represented by the Formula (I) wherein Ar, R1-R6 are defined herein. Compounds having Formula (I) are PARP inhibitors. Therefore, compounds of the invention may be used to treat clinical conditions that are responsive to the inhibition of PARP activity.
    Type: Application
    Filed: March 31, 2012
    Publication date: January 23, 2014
    Applicant: Impact Therapeutics, Inc.
    Inventors: Sui Xiong Cai, Ye Edward Tian, Haijun Dong, Qingbing Xu, Lizhen Wu, Lijun Liu, Yangzhen Jiang, Qingli Bao, Guoxiang Wang, Feng Yin, Chengyun Gu, Xiuhua Hu, Xiaozhu Wang, Sishun Kang, Shengzhi Chen